Jinxin Capital
VC Fund
Jinxin Capital is a venture capital firm.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Jinxin Capital invests in
Stages Jinxin Capital invests in
Countries Jinxin Capital invests in
Investment Focus
Industry
- Medical 6 (86%)
- Health Care 4 (57%)
- Biotechnology 2 (29%)
- Medical Device 2 (29%)
- Solar 1 (14%)
Stage
- Seed 2 (29%)
- Series A 2 (29%)
- Series B 2 (29%)
- Series D 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GCL Optoelectronics
|
GCL Optoelectronics is a supplier of perovskite solar modules, focusing on the R&D and production of perovskite solar modules. | $14.8M / Series D / Aug 03, 2026 | |
Bangqi Biological
|
Bangqi Biological is a biotechnology company that focuses on the research and development, production, registration, quality, supply chain and sales of instruments and reagents for autoimmunity & allergy diagnosis. | Series B / Nov 27, 2024 | |
Shengxing Medical
|
Shengxing Medical is a high-tech company that specializes in the research and development of medical imaging holographic preoperative planning systems, as well as holographic intelligent surgical positioning and navigation systems. | $1.4M / Seed / Sep 12, 2024 | |
Shineyo Medical
|
Shineyo Medical is a provider of minimally invasive cardiovascular interventional treatment devices, focusing on electrophysiology and peripheral intervention. They aim to become a domestic provider of solutions for atrial fibrillation and varicose veins. | $13.9M / Series A / Aug 12, 2024 | |
|
Meishangjie Biotechnology
|
Meishangjie Biotechnology is a biotech firm that specializes in the genetic engineering synthetic biotechnology for medical skin care products. | Series A / Jul 09, 2024 | |
New Cloud Medical
|
New Cloud Medical is the leading pain specialist medical association in China. It relies on the national key specialists, the Sino-Japanese Hospital Pain Specialist Medical Association, the national telemedicine platform, the top hospital brand and the expert resource library, making full use of the advantages of international pain disciplines.Construction of national, provincial, municipal, and county pain cloud platform grading clinics. Providing pain-specific specialty treatments to city-level and county-level public secondary hospitals, creating city-level and characteristic pain departments, improving the level of pain specialist treatment, and building a professional and comprehensive network of consultation consultations and a long-term scientific operation system. | Series B / Sep 25, 2023 | |
|
Jingcai Intelligent
|
Jingcai Intelligent is an AI company that focuses on the continuous management of musculoskeletal pain and sports health. Jingcai Intelligent provides digital screening and functional evaluation, health An overall solution for management and scientific training. | Seed / Jun 20, 2023 |
Co-Investors
Zhangjiagang Industrial Capital
2 deals together
Guangzhou Financial Holding Fund Management
1 deal together
Industrial Securities Capital
1 deal together
Lucion
1 deal together
HongShan
1 deal together
Shanghai Jiusong Shanhe Equity Investment Fund Management
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Jinxin Capital invest in?
Jinxin Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jinxin Capital last invest?
The most recent investment recorded for Jinxin Capital closed in Aug 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
